New Delhi, June 11 -- The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, Government of India, organized a Scientific Conclave and Interactive Session on Indian Pharmacopoeia (IP) 2026 "Strengthening Pharmaceutical Manufacturing through Pharmacopoeial Standards and Quality Compliance" at Haridwar on Wednesday, in collaboration with the Association of Devbhumi Pharma Industries (ADPI) and affiliated pharmaceutical manufacturing associations of Uttarakhand.

The conclave was organised with the objective of enhancing awareness on the provisions of IP 2026 and promoting quality compliance across the pharmaceutical manufacturing sector.

Uttarakhand is one of India's leading pha...